Mark S. Gold

10.6k total citations · 2 hit papers
243 papers, 7.1k citations indexed

About

Mark S. Gold is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Mark S. Gold has authored 243 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Cellular and Molecular Neuroscience, 62 papers in Clinical Psychology and 43 papers in Psychiatry and Mental health. Recurrent topics in Mark S. Gold's work include Neurotransmitter Receptor Influence on Behavior (69 papers), Eating Disorders and Behaviors (31 papers) and Substance Abuse Treatment and Outcomes (26 papers). Mark S. Gold is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (69 papers), Eating Disorders and Behaviors (31 papers) and Substance Abuse Treatment and Outcomes (26 papers). Mark S. Gold collaborates with scholars based in United States, Israel and Hungary. Mark S. Gold's co-authors include Charles A. Dackis, Norman S. Miller, A.L.C. Pottash, Nicole M. Avena, Steven T. Szabo, Kimberly Frost-Pineda, James A. Cocores, Adriaan W. Bruijnzeel, Nathan A. Shapira and Jeffrey M. Jonas and has published in prestigious journals such as The Lancet, JAMA and PLoS ONE.

In The Last Decade

Mark S. Gold

235 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Problematic internet use: Proposed classification and diagnostic criteria

2003 584 citations Mark S. Gold et al. profile →
New concepts in cocaine addiction: The dopamine depletion hypothesis

1985 507 citations Mark S. Gold et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Gold United States	45	2.0k	1.8k	979	952	908	243	7.1k
Andrew Smolen United States	44	1.4k 0.7×	2.1k 1.2×	904 0.9×	587 0.6×	770 0.8×	138	6.4k
Joy M. Schmitz United States	45	2.3k 1.1×	2.3k 1.3×	801 0.8×	837 0.9×	1.7k 1.8×	218	8.4k
HonaLee Harrington United States	11	1.3k 0.6×	3.3k 1.9×	690 0.7×	609 0.6×	990 1.1×	12	8.4k
Gilberto Gerra Italy	45	1.6k 0.8×	1.3k 0.8×	635 0.6×	854 0.9×	713 0.8×	152	5.8k
Falk Kiefer Germany	49	2.3k 1.1×	1.3k 0.7×	754 0.8×	505 0.5×	698 0.8×	308	7.3k
Karen Sugden United Kingdom	37	1.5k 0.7×	3.5k 2.0×	1.6k 1.6×	869 0.9×	1.5k 1.7×	75	11.4k
Redford B. Williams United States	61	883 0.4×	3.3k 1.8×	465 0.5×	1.0k 1.1×	1.0k 1.2×	238	12.8k
James C. Overholser United States	51	2.0k 1.0×	3.5k 2.0×	1.6k 1.6×	451 0.5×	1.1k 1.2×	239	9.5k
Luigi Janiri Italy	48	1.1k 0.5×	2.9k 1.7×	510 0.5×	485 0.5×	1.9k 2.1×	261	7.8k
Helen Fox United Kingdom	43	1.7k 0.8×	1.2k 0.7×	665 0.7×	378 0.4×	595 0.7×	112	6.1k

Countries citing papers authored by Mark S. Gold

Since Specialization

Citations

This map shows the geographic impact of Mark S. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Gold more than expected).

Fields of papers citing papers by Mark S. Gold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Gold. The network helps show where Mark S. Gold may publish in the future.

Co-authorship network of co-authors of Mark S. Gold

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Gold. A scholar is included among the top collaborators of Mark S. Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Gold. Mark S. Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghafouri, Mohammad, et al.. (2024). Treatments for Cannabis Use Disorder Across the Lifespan: A Systematic Review. Preprints.org. 1 indexed citations

Gold, Mark S., et al.. (2024). A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder. Brain Sciences. 14(3). 294–294. 10 indexed citations

Blum, Kenneth, Thomas McLaughlin, Mark S. Gold, et al.. (2023). Are We Getting High Cause the Thrill is Gone?. PubMed. 7(1). 5–516. 1 indexed citations

Blum, Kenneth, Paul R. Carney, Panayotis K. Thanos, et al.. (2023). Psychostimulants for Children: Are We Over or Under Dosing?. PubMed. 7(1). 1–4.

Yao, Rutao, et al.. (2023). Exercise Modifies the Brain Metabolic Response to Chronic Cocaine Exposure Inhibiting the Stria Terminalis. Brain Sciences. 13(12). 1705–1705. 4 indexed citations

Blum, Kenneth, Igor Elman, Abdalla Bowirrat, et al.. (2022). Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?. Journal of Personalized Medicine. 12(10). 1719–1719. 10 indexed citations

Blum, Kenneth, Thomas McLaughlin, Abdalla Bowirrat, et al.. (2022). Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?. Journal of Personalized Medicine. 12(2). 321–321. 23 indexed citations

Modestino, Edward J., Kenneth Blum, Debasis Bagchi, et al.. (2022). Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of Personalized Medicine. 12(12). 1946–1946. 11 indexed citations

Blum, Kenneth, Abdalla Bowirrat, Jag Khalsa, et al.. (2022). Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. 6(3). 27–27. 8 indexed citations

10.

Braverman, Eric R., Mark S. Gold, Abdalla Bowirrat, et al.. (2022). Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”. International Journal of Environmental Research and Public Health. 19(9). 5480–5480. 7 indexed citations

11.

Madigan, Margaret, Ashim Gupta, Abdalla Bowirrat, et al.. (2022). Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?. International Journal of Environmental Research and Public Health. 19(11). 6395–6395. 5 indexed citations

12.

Gupta, Ashim, Abdalla Bowirrat, David Baron, et al.. (2022). Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors. International Journal of Environmental Research and Public Health. 19(1). 552–552. 7 indexed citations

13.

Blum, Kenneth, Abdalla Bowirrat, Panayotis K. Thanos, et al.. (2022). Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. Journal of Personalized Medicine. 12(11). 1864–1864. 6 indexed citations

14.

Blum, Kenneth, Abdalla Bowirrat, Eric R. Braverman, et al.. (2021). Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. International Journal of Environmental Research and Public Health. 18(21). 11529–11529. 15 indexed citations

15.

Blum, Kenneth, Edward J. Modestino, Debasis Bagchi, et al.. (2021). A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. Journal of Personalized Medicine. 11(3). 212–212. 15 indexed citations

16.

Oesterle, Tyler, Scott Breitinger, Larissa L. Loukianova, et al.. (2020). Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era. Mayo Clinic Proceedings. 95(12). 2709–2718. 83 indexed citations

17.

Blum, Kenneth, Jean Lud Cadet, David Baron, et al.. (2020). Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?. Substance Use & Misuse. 55(14). 2438–2442. 17 indexed citations

18.

Blum, Kenneth, David Han, Edward J. Modestino, et al.. (2017). A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone. Substance Use & Misuse. 53(2). 220–229. 25 indexed citations

19.

Bowirrat, Abdalla, Thomas J.H. Chen, Kenneth Blum, et al.. (2010). Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability. Current Neuropharmacology. 8(4). 335–358. 45 indexed citations

20.

Gold, Mark S. & A.L.C. Pottash. (1986). Diagnostic and laboratory testing in psychiatry. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact